Imagine using CRISPR technology to create drought-resistant wheat. Rice that can thrive in saltwater environments. Bananas that stay fresh for weeks without browning. Nutrient-packed tomatoes that may help lower blood pressure. Crops engineered to resist diseases without the need for any pesticides.
This is not science fiction. It is CRISPR — and it is already happening on farms, in research labs, and on supermarket shelves in countries across the world.
CRISPR gene editing is arguably the most significant agricultural technology since the Green Revolution of the 1960s. It is faster than traditional breeding, more precise than conventional genetic modification, cheaper than either, and scientifically capable of addressing some of the most pressing challenges facing global agriculture: climate change, food insecurity, crop disease, and nutritional deficiency.
Understanding what CRISPR is, how it works in crops, what has already been approved and commercialised, and what the future holds — is essential reading for anyone interested in agriculture, food security, or the science shaping our food supply.
What is CRISPR — and why does it matter for Agriculture?
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. It is a naturally occurring mechanism that bacteria use to defend themselves against viruses. Scientists discovered that they could harness this system — combined with a protein called Cas9 — as a precise molecular tool for editing DNA.
The discovery of CRISPR-Cas9 in 2012 has the potential to accelerate the pace of innovation and enable more precise interventions in biological systems. Since then, it has moved with extraordinary speed from laboratory curiosity to commercial application.
In agriculture, CRISPR works by acting as a pair of molecular scissors. Scientists design a guide RNA — a short sequence of genetic code — that directs the Cas9 protein to a precise location in a plant’s genome. Once there, it cuts the DNA. The plant’s own repair mechanisms then either disable the targeted gene or allow scientists to introduce a specific change. The result is a plant with a precisely edited genome — and crucially, in many applications, no foreign DNA from another organism.
This last point is important. It is what distinguishes many CRISPR-edited crops from conventional genetically modified organisms (GMOs). Traditional GMO technology typically involves inserting genes from a completely different species into a plant’s genome — a process that triggers significant regulatory scrutiny and significant public unease. CRISPR, when used to disable or fine-tune existing genes without adding foreign DNA, produces a result that could theoretically have occurred through conventional breeding — just far faster and with far greater precision.
CRISPR vs Traditional Breeding vs GMO: Understanding the Difference
To appreciate why CRISPR is generating such excitement — and such debate — it helps to understand where it sits in the history of crop improvement.
Traditional breeding has been the foundation of agricultural progress for ten thousand years. Farmers select plants with desirable traits and cross them over generations to fix those traits in a variety. It works, but it is extraordinarily slow — typically taking ten to fifteen years to develop and commercialise a new variety — and it is imprecise, because crossing plants shuffles thousands of genes simultaneously, with no control over which ones move together.
Conventional GMO technology, developed from the 1970s onward, dramatically accelerated the ability to introduce new traits by inserting specific genes from other organisms. But it came with complications: intense public controversy, stringent regulatory processes, high development costs, and significant intellectual property concentration in the hands of large agrochemical corporations.
CRISPR occupies a different position. It can achieve in months what conventional breeding takes decades to accomplish. It makes edits that are indistinguishable from natural mutations. It is dramatically cheaper than conventional GM development. And when used without foreign DNA insertion, it avoids many of the regulatory and public perception challenges that have dogged GMO agriculture.
Prime editing — one of the latest advances in CRISPR technology — combines CRISPR-Cas9 with a reverse transcriptase and has the potential to correct up to 89 per cent of known genetic variants, enabling direct editing of target DNA sequences. Base editing allows the direct and irreversible conversion of one DNA base into another, increasing the precision of point mutations still further. These advances are making CRISPR an increasingly powerful and versatile toolkit for crop improvement.
What can CRISPR actually do for Crops?
The range of agricultural applications being developed using CRISPR technology is extraordinary. Here is a breakdown of the major categories:
Disease Resistance
Crop diseases cause billions of dollars in losses every year. CRISPR is being used to build disease resistance into crops at the genetic level — eliminating the need for pesticide applications and providing farmers with durable protection against pathogens that can evolve rapidly.
Research has demonstrated successful CRISPR-mediated disease resistance across numerous economically important crop species, with some achieving broad-spectrum resistance against multiple pathogens simultaneously. CRISPR-edited wheat varieties with resistance to powdery mildew — a fungal disease that annually destroys significant proportions of the global wheat crop — are among the most advanced examples.
Drought and Climate Resilience
This is arguably where CRISPR’s potential is greatest and most urgent. As climate change makes rainfall less predictable and droughts more frequent and severe, the ability to edit crops for drought tolerance, heat resistance, and water-use efficiency is becoming a food security imperative.
In India, the Indian Council of Agricultural Research has leveraged gene editing tools to improve two mega varieties, releasing them in May 2025 as DRR Dhan 100 (Kamala) and Pusa DST Rice 1. These plants are tolerant to salinity and drought, respectively and reduce greenhouse gas emissions by 20 percent while requiring less water — a remarkable combination of climate adaptation and environmental benefit delivered through precision gene editing.
Research is also advancing on cold tolerance in soybeans, heat resistance in wheat, and salinity tolerance in multiple staple crops — all traits that will become more critical as global temperatures continue to rise.
Nutritional Enhancement
CRISPR is being used to improve the nutritional profiles of crops consumed by billions of people. Applications include increasing iron and zinc content in staple crops where deficiency is a major public health problem, improving amino acid profiles in cereals and legumes, and boosting levels of vitamins and health-promoting compounds.
In Japan, CRISPR-edited tomatoes enriched with gamma-aminobutyric acid (GABA) — a compound associated with blood pressure reduction and stress relief — became the world’s first commercialised CRISPR food product. These tomatoes were sold directly to Japanese consumers as a functional food, marking a milestone for CRISPR crop commercialisation. Japan’s regulators allowed these to be sold without treating them as GMOs, since no foreign DNA was inserted.
Reduced Post-Harvest Losses
Food waste is one of the most significant and underaddressed challenges in global food systems. CRISPR is being applied to extend shelf life and reduce browning and spoilage in a range of crops. Non-browning bananas, longer-lasting strawberries, and potatoes that produce fewer harmful compounds when fried are among the products in development or already cleared for commercialisation. Recent breakthroughs include work on seedless blackberries and pitless cherry varieties, with companies like Pairwise promising fruits and vegetables of the future.
Yield Improvement
More than 55 rice genes have been subjected to editing using the CRISPR-Cas approach for traits including plant architecture and grain yield. Editing genes that control plant architecture — stem height, leaf angle, tillering — can improve light capture, reduce lodging, and increase the number of grains per plant. These are traits that traditional breeders have worked on for generations; CRISPR accelerates the process dramatically.
Reduced Environmental Impact
CRISPR is also being used to reduce agriculture’s environmental footprint directly. Crops edited to fix their own atmospheric nitrogen — reducing dependence on synthetic fertilisers — are in development. CRISPR-edited cover crops with enhanced oil profiles for biofuel use are approaching commercial markets in the USA. And gene editing is being used to develop livestock with reduced methane emissions — addressing one of agriculture’s largest contributions to greenhouse gas emissions.
CRISPR Crops: What Is Already Approved and on the Market?
The gap between laboratory promise and commercial reality in agricultural biotechnology is often enormous. So, where does CRISPR currently stand in terms of actual products approved and available?
Several gene-edited crops have been approved for commercialisation in the United States, including soybean, canola, rice, maize, mushroom, tomatoes, and camelina. The USA, under the USDA’s revised 2020 regulatory framework — which takes a more science-based, risk-proportionate approach to gene-edited crops — has been among the most permissive regulatory environments for CRISPR agriculture.
Notable specific examples include:
- GABA Tomatoes (Japan): The world’s first CRISPR food product, sold to Japanese consumers as a functional food. Japan’s exemption of no-foreign-DNA edits from its GMO regulatory process made Japan the fastest major market for CRISPR food commercialisation.
- CRISPR Fish (Japan): By 2022, Japanese markets saw faster-growing red sea bream and tiger puffer fish developed with CRISPR, approved and sold after developers registered the edits without going through the GMO approval process.
- High-GABA Tomatoes and Camelina Oil (USA): Multiple products, including camelina with enhanced omega-3 oil profiles, have been cleared by US regulators and are reaching the market.
- DRR Dhan 100 and Pusa DST Rice 1 (India, 2025): Released in May 2025, these climate-resilient rice varieties represent the developing world’s first major commercialisation of CRISPR-improved staple food crops — a landmark moment for agricultural gene editing beyond the high-income world.
- In the pipeline: Nutrient-enhanced tomatoes, pathogen-resistant fish and cereal crops, potatoes that make for healthier chips and fries, seedless blackberries, and pitless cherries are among the products advancing toward commercialisation from academic and private-sector research programs.
The CRISPR-based gene editing market is growing at a compound annual growth rate of 12.30 percent from 2025 to 2034, with the market expected to surpass USD 13.39 billion by 2034. North America currently dominates this market, driven by a robust culture of biotechnology innovation and strong research infrastructure.
The Regulatory Landscape: A World Divided
Perhaps no aspect of CRISPR agriculture is more complex or more consequential than regulation. The global regulatory landscape for gene-edited crops is deeply fragmented — and the differences between countries have enormous implications for who benefits from the technology and how quickly.
- United States: The most permissive of the major agricultural economies. The USDA revised its regulatory framework in 2020 to be more science-based and risk-proportionate, effectively exempting many CRISPR edits that could have occurred through conventional breeding from the full GMO approval process. This has significantly accelerated US CRISPR crop development.
- Japan has taken a similarly progressive approach, exempting no-foreign-DNA CRISPR edits from its GMO regulations. This made Japan the first country to commercialise a CRISPR food product.
- European Union: The most restrictive major market. The EU currently classifies CRISPR-edited crops as GMOs, subjecting them to the same rigorous and expensive regulations as conventional transgenic crops — a framework that has significantly hindered the development and commercialisation of CRISPR crops in Europe, including CRISPR-edited wheat. Proposals to update EU regulations to allow a lighter regulatory touch for certain gene-edited crops have been under discussion, but progress has been slow and politically contentious.
- Argentina and Brazil: Have adopted relatively flexible regulatory frameworks focused on the final product rather than the process, allowing CRISPR-edited crops, including sugarcane, with less regulatory burden.
- China: Has historically been cautious with GMOs but is now pivoting toward gene editing for food security. China’s investment in CRISPR research, particularly in rice, positions it as a major player in the field.
- India: The 2025 commercialisation of two CRISPR rice varieties represents a significant shift in India’s regulatory approach, signalling growing openness to gene editing as a tool for food security and climate adaptation.
The debate between treating CRISPR crops as GMOs or as a distinct regulatory category is likely to persist until a universal, transparent, science-based, and scalable regulatory system is developed internationally. How this debate is resolved will significantly determine how quickly and equitably CRISPR’s agricultural potential is realised.
CRISPR vs GMO: The Controversy Explained
Public attitudes toward agricultural biotechnology are complex and often shaped more by perception than by scientific evidence. Understanding the distinction between CRISPR and conventional GMO technology is essential for navigating the public debate.
The core controversy around conventional GMOs centres on the introduction of foreign genes — from bacteria, viruses, or other organisms — into plant genomes, producing combinations that could not occur naturally. This “transgenic” approach triggers both regulatory scrutiny and public concern about unintended consequences, corporate control of the food supply, and philosophical objections to crossing species boundaries.
CRISPR muddies this picture significantly. When CRISPR is used to make small edits — disabling a gene, correcting a mutation, adjusting expression levels — without introducing any foreign DNA, the resulting plant contains no genetic material that could not have appeared through natural mutation or conventional breeding. Critics argue that even this is “unnatural” because it accelerates and directs a process that would take nature or conventional breeding much longer. Proponents counter that this is precisely the point — that the precision and speed of CRISPR is its greatest advantage over both slow conventional breeding and the cruder insertions of first-generation GMO technology.
The ethical debate also includes potential unintended consequences, the creation of organisms with unpredicted effects on ecosystems, the long-term ecological impacts of releasing gene-edited organisms into agricultural environments, and the concentration of intellectual property in large corporations. Intellectual property issues governing CRISPR tools are among the major bottlenecks in commercialising edited crops, particularly for public-sector researchers in developing countries who may lack access to the required patents.
These are legitimate concerns that deserve serious scientific and regulatory engagement — not dismissal. The history of agricultural biotechnology contains enough cautionary tales to justify careful assessment of novel technologies, even when the science appears clean.
CRISPR and Food Security: The Developing World Dimension
Perhaps the most important and least discussed dimension of CRISPR agriculture is its potential for food security in low- and middle-income countries.
Unlike conventional GMO technology, which has largely been dominated by private-sector investment in a small number of commodity crops primarily grown by large commercial farmers in rich countries, CRISPR technology is potentially accessible to public-sector researchers and applicable to the full range of crops — including orphan crops and staple foods — grown by smallholder farmers in Africa, Asia, and Latin America.
The involvement of the public sector can alleviate the barriers to providing access to smallholders. The CGIAR international agricultural research centres are using gene editing for crop and livestock improvement, taking advantage of its less controversial nature compared to conventional GMO approaches.
Crops like teff — a staple grain in Ethiopia — cowpea, cassava, sorghum, and millet are among the crops where CRISPR could deliver transformative improvements in drought tolerance, disease resistance, and nutritional value for farming communities that have historically been bypassed by both conventional breeding programs and GMO investment.
Countries with relatively underdeveloped research infrastructure and manpower will need support through investments and partnerships to fully benefit, but the directional potential is clear. CRISPR could democratise agricultural biotechnology in a way that conventional GMO technology never did.
The Future of CRISPR Agriculture: What Comes Next?
The trajectory of CRISPR in agriculture over the next decade will be shaped by three intersecting forces: scientific advancement, regulatory evolution, and public acceptance.
On the scientific side, the technology is advancing rapidly. CRISPR-GPT — an AI system developed to automate gene-editing workflows from guide RNA design to data interpretation — is integrating artificial intelligence with molecular biology, drastically reducing the time between discovery and application. Digital twins of agricultural systems, robotic high-throughput plant phenotyping, and advanced delivery methods for CRISPR components into plant cells are all accelerating the speed at which new edited varieties can be developed and tested.
On the regulatory side, the pressure to modernise frameworks — particularly in the European Union — is growing, driven by competitive pressure from more permissive markets, scientific consensus that no-foreign-DNA edits present no greater risk than conventional breeding, and the urgent agricultural challenge of climate adaptation.
On the public acceptance side, consumer attitudes are evolving — though unevenly. The commercialisation of CRISPR foods in Japan, with consumer labelling and transparent communication, has proceeded without the backlash that accompanied early GMO commercialisation. As more CRISPR products reach markets and consumers have the opportunity to evaluate them on their actual characteristics — taste, nutrition, price, sustainability — rather than on abstract fears, acceptance is likely to grow.
The crops of the next twenty years — the wheat that feeds ten billion people on a hotter, drier planet, the rice that grows in the flooded fields of a more chaotic climate, the vegetables that deliver more nutrition per bite from smaller areas of farmland — will almost certainly bear the fingerprints of CRISPR editing.
Conclusion: A Precision Tool for an Imprecise World
Agriculture faces a convergence of challenges that have no easy solutions: a changing climate disrupting production patterns, a growing global population requiring more food from less land, water scarcity threatening irrigation-dependent systems, and the erosion of soil health accumulated over millennia.
CRISPR does not solve all of these problems. It is a tool — a remarkably precise, versatile, and powerful tool — but a tool nonetheless. It works best when embedded in broader agricultural systems that address the social, economic, and institutional dimensions of food security alongside the biological ones.
But as tools go, CRISPR is extraordinary. The ability to make precise, targeted improvements to crops in months rather than decades — to build drought tolerance into wheat before the next major drought, to engineer disease resistance into banana varieties before the next wave of Panama disease, to improve the nutritional quality of staple crops eaten by billions of people — represents a genuine expansion of humanity’s capacity to feed itself on a challenging planet.
The gene-editing revolution in agriculture is not coming. It is already here. The question is not whether CRISPR will transform our crops — it is how quickly, how equitably, and how wisely we deploy it.